Details of the Drug-Related molecule(s) Interaction Atlas

General Information of DTT (ID: TTIF29E)

Molecule-Related Drug & Molecule List

Molecule-Related Drug List

Molecule Type:

DTT

DTP

DME

Drug Status:

Clinical Trial Drug(s)

Patented Agent(s)

Download the Complete Related Drug List

1 Clinical Trial Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
MEDI8367	DM7L053	Chronic kidney disease	GB61	Phase 1	[1]
------------------------------------------------------------------------------------

3 Patented Agent(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
US10035778, Example 1	DM28XHN	N. A.	N. A.	Patented	[2]
US10035778, Example 12	DMBN6W2	N. A.	N. A.	Patented	[2]
US10035778, Example 16	DMJ53DR	N. A.	N. A.	Patented	[2]
------------------------------------------------------------------------------------

Molecule Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

References

1	ClinicalTrials.gov (NCT04365218) A Phase I Randomized, Blinded, Placebo-controlled Study to Evaluate the Safety and Pharmacokinetics of MEDI8367 Administered as Single Ascending Doses in Healthy Subjects, and as a Single Dose in Healthy Subjects of Japanese-descent and in Subjects With Chronic Kidney Disease. U.S.National Institutes of Health.
2	Meta-azacyclic amino benzoic acid derivatives as pan integrin antagonists. US10035778.